Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zosano Pharma Corp.
DescriptionGlucagon delivered using Zosano's microneedle patch system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHypoglycemia
Indication DetailsTreat severe hypoglycemia; Treat severe hypoglycemia in Type I diabetics
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today